Wolters Kluwer N.V. (WOLTF)
| Previous close | 97.51 |
| Open | 97.51 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 97.51 - 97.51 |
| 52-week range | 87.35 - 114.20 |
| Volume | |
| Avg. volume | 91 |
| Market cap | 24.54B |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | 31.25 |
| EPS (TTM) | 3.12 |
| Earnings date | N/A |
| Forward dividend & yield | 1.71 (1.76%) |
| Ex-dividend date | 30 Aug 2022 |
| 1y target est | N/A |
- Business Wire
Wolters Kluwer Compliance Solutions to present "Disruption Continuum for Auto Finance" webinar
MINNEAPOLIS, September 22, 2022--Hear Wolters Kluwer insights on "The Disruption Continuum: Auto Financers Shift into a Digital-first Era," in a free webinar 2-3 pm EDT Weds. Sept. 28
- GlobeNewswire
Share Buyback Transaction Details September 15 – September 21, 2022
Share Buyback Transaction Details September 15 – September 21, 2022 September 22, 2022 - Wolters Kluwer (Euronext: WKL), a global leading provider of expert solutions, insights and services for professionals, today reports that it has repurchased 295,990 of its own ordinary shares in the period from September 15, 2022, up to and including September 21, 2022, for €29.7 million and at an average share price of €100.40. These repurchases are part of the share buyback program under which we intend t
- Business Wire
Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness
WALTHAM, Mass., September 21, 2022--Wolters Kluwer, Health today announced that Christopher Sullivan has been appointed as Vice President and General Manager of the Commercial Segment for Clinical Effectiveness.
